CAS: 1373422-53-7
![N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine](https://static.cymitquimica.com/products/IN/thumb/DA003AG4.jpg)
N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine
CAS:1373422-53-7
Formula:
C22H23N5O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
389.4503
Ref: IN-DA003AG4
| 5mg | 74.00 € | ||
| 10mg | 101.00 € | ||
| 25mg | 196.00 € | ||
| 50mg | 236.00 € | ||
| 100mg | 530.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 7W-GW4131
| 1mg | 170.00 € | ||
| 5mg | 241.00 € | ||
| 10mg | 383.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
GSK-J1
CAS:1373422-53-7
GSK-J1 is a highly potent H3K27 histone demethylase inhibitor with IC50 of 28 nM and …
Formula:
C22H23N5O2
Purity:
99.67% - 99.67%
Color and Shape:
Solid
Molecular weight:
389.45
Ref: TM-T6847
| 5mg | 47.00 € | ||
| 10mg | 68.00 € | ||
| 25mg | 95.00 € | ||
| 50mg | 175.00 € | ||
| 100mg | 289.00 € | ||
| 1mL*10mM (DMSO) | 73.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
GSK J1
Controlled ProductCAS:1373422-53-7
Formula:
C22H23N5O2
Color and Shape:
Neat
Molecular weight:
389.45
Ref: TR-G797553
| 100mg | 2,137.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
GSK-J1
CAS:1373422-53-7
GSK-J1 is a peptide that inhibits protein interactions by binding to the receptor and blocking …
Formula:
C22H23N5O2
Purity:
Min. 95%
Molecular weight:
389.45 g/mol
Ref: 3D-YEC42253
| 10mg | 304.00 € | ||
| 100mg | 1,140.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
